Señales en vivo de DVAX | Maximiza tus Ganancias con Getagraph.com

VENDER 117369 min ago

@ $12.42

Emitido: 14 feb 2024 @ 09:30

Retorno: -5.48%

Señal anterior: feb 12 - 15:56

Señal anterior: Comprar

Retorno: -2.97 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	1.82M
Volumen promedio	1.96M
Capitalización de mercado	1.53B
EPS	$0 ( 2024-02-22 )
Próxima fecha de ganancias	( $-0.0500 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-234.80
ATR14	$0.0100 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-29	Slebir John L	Sell	0	Common Stock
2024-03-29	Slebir John L	Sell	300 000	Stock Option (Right to Buy)
2024-03-29	Slebir John L	Sell	80 000	Stock Options (Right to Buy)
2024-03-29	Slebir John L	Sell	50 000	Restricted Stock Unit
2024-03-29	Slebir John L	Sell	88 000	Stock Options (Right to Buy)

INSIDER POWER
-33.81
Last 100 transactions
Buy: 1 153 769 \| Sell: 2 721 592

Volumen Correlación

Largo: -0.68 (moderate negative)

Corto: -0.54 (weak negative)

Signal:(25.399) Neutral

Dynavax Technologies Corp Correlación

10 Correlaciones Más Positivas
RMRM	0.942
SUSL	0.937
PABU	0.935
DCFC	0.935
CATH	0.933
CACG	0.932
CLNE	0.93
NUTX	0.929
VONE	0.929
TROO	0.927

10 Correlaciones Más Negativas
SDVY	-0.926
VC	-0.925
RAIN	-0.924
OSIS	-0.923
HLNE	-0.922
AMTBB	-0.921
NYMTM	-0.92
PSCI	-0.919
RNSC	-0.919
RAM	-0.918

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dynavax Technologies Corp Correlación - Moneda/Commodity

0.62
( weak )

0.39
( neutral )

0.00
( neutral )

0.79
( moderate )

-0.64
( weak negative )

Dynavax Technologies Corp Finanzas

Annual	2023
Ingresos:	$232.28M
Beneficio Bruto:	$182.12M (78.40 %)
EPS:	$-0.0496

FY	2023
Ingresos:	$232.28M
Beneficio Bruto:	$182.12M (78.40 %)
EPS:	$-0.0496

FY	2022
Ingresos:	$722.68M
Beneficio Bruto:	$460.53M (63.73 %)
EPS:	$2.32

FY	2021
Ingresos:	$439.44M
Beneficio Bruto:	$265.87M (60.50 %)
EPS:	$0.620

Financial Reports:

No articles found.

Dynavax Technologies Corp

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Actualizaciones en tiempo real para Dynavax Technologies Corp [DVAX]

Upcoming Earnings Alert